US court: drug innovators can be liable for injuries by generics
This article was originally published in SRA
Executive Summary
The top court of the US state of Alabama has reaffirmed its decision last year that brand-name drug makers like Pfizer can be held liable for a lack of warnings on generic forms of their medicines. The ruling could have implications in other lawsuits1,2.